The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index; 9 of the 125 sources its claims cite were checked for support.
Synthesis and Biological Application of Polylactic Acid
Open accessAbstract
Over the past few decades, with the development of science and technology, the field of biomedicine has rapidly developed, especially with respect to biomedical materials. Low toxicity and good biocompatibility have always been key targets in the development and application of biomedical materials. As a degradable and environmentally friendly polymer, polylactic acid, also known as polylactide, is favored by researchers and has been used as a commercial material in various studies. Lactic acid, as a synthetic raw material of polylactic acid, can only be obtained by sugar fermentation. Good biocompatibility and biodegradability have led it to be approved by the U.S. Food and Drug Administration (FDA) as a biomedical material. Polylactic acid has good physical properties, and its modification can optimize its properties to a certain extent. Polylactic acid blocks and blends play significant roles in drug delivery, implants, and tissue engineering to great effect. This article describes the synthesis of polylactic acid (PLA) and its raw materials, physical properties, degradation, modification, and applications in the field of biomedicine. It aims to contribute to the important knowledge and development of PLA in biomedical applications.
Overview
CoChat Summary
TL;DR
This review summarizes polylactic acid (PLA) synthesis, physical properties, degradation, modification, and biomedical applications. It highlights PLA’s biocompatibility and biodegradability while noting challenges in mechanical properties, nanoparticle drug-delivery commercialization, and production cost.
Key findings
- PLA is a biodegradable, biocompatible polymer approved by the FDA for biomedical use; it is made from lactic acid, which is traditionally obtained by sugar fermentation, and exists as PLLA, PDLA, and PDLLA.
- Key properties include processing temperatures of 170–230 °C; PLLA and PDLA melting points of 207 °C; racemic crystals with a melting point of 230 °C and ultimate tensile strength of 50 MPa; a glass transition temperature of 55 °C for PLA of 22,000 g mol−1; and a heat of fusion of 93.7 J g−1 for 100% pure crystals.
- Modification by copolymerization, blending, plasticizers, or crosslinking can improve PLA’s hydrophobicity, toughness, and degradation; examples include PLA–PEG hemoglobin microcapsules reaching a 90% embedding rate versus 7.9% for PLA alone, a PLA–naltrexone complex with 67% in vitro release at 35 days, and PLA–PEG–PLA paclitaxel microspheres with 49% release in one month.
- Biomedical applications include tissue engineering, drug delivery, and implants; PLA-based stents are commercialized, and 3D-printed PLA scaffolds are reported to cause less inflammation, but no PLA nanoparticle has been successfully marketed for drug delivery.
Methods
- Narrative review of PLA synthesis, raw materials, physical properties, degradation, modification, and biomedical applications; no primary experimental data, sample, or systematic search strategy is described.
- Main analysis is qualitative synthesis of cited literature and selected examples, with no meta-analysis or statistical pooling.
Limitations
- The paper states that PLA suffers from brittleness, poor mechanical properties, slow crystallization speed, and low crystallinity; it also states that drug-delivery nanoparticles face challenges including side effects, toxicity, size/position/shape issues, positive-charge cytotoxicity, oxidative stress, DNA damage, ROS-related inflammation, hemolysis risk, complex disease microenvironments, and blood interactions, and that commercialization is limited by price and raw-material production efficiency.
- Evident from the text: as a narrative review, it lacks systematic search/inclusion criteria and quantitative synthesis, and many claims rely on cited secondary literature without new experimental validation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Synthesis of polylactic acid (PLA) from l- and d-lactic acids [28]. Adapted from Auras et al. by permission of Wiley–VCH Verlag GmbH & Co. KGaA.](https://figures.cochat.ai/paper-figures/c0c15b60797046e2a98a260168f15ebf/synthesis-and-biological-application-of-polylactic-acid-figure-2.jpg)

![Figure 4 High drug loading and pH-responsivity PLA-g-doxorubicin (DOX) nanoparticles [99]. Reprinted from Cheng with permission from Express Polymer Letters.](https://figures.cochat.ai/paper-figures/f2964f7b6801471a93511477c2ba67d7/synthesis-and-biological-application-of-polylactic-acid-figure-4.jpg)
![Figure 5 Schematic illustration of the concept of stereocomplex hydrogel formed by mixing aqueous solutions of bio-polymers containing enantiomeric oligo(lactic acid) [125]. Reprinted from Nostrum with permission from Express Polymer Letters.](https://figures.cochat.ai/paper-figures/7afa96ad62934c7c95f90c9477ca9c3d/synthesis-and-biological-application-of-polylactic-acid-figure-5.jpg)
Verification
Claims the paper makes
4 Valid · 0 Not valid · 64 Not checked · 10 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“The degree of crystallinity affects the degradation of PLA [52,53].”
§ Synthesis and Biological Application of Polylactic Acid > 2. PLA Synthesis and Properties > 2.3. PLA Properties
What the sources say
- Could not verifycites [52] Li, 2007, Effect of nucleation and plasticization on the crystallization of poly (lactic acid), Polymer sourceExperimental — accuracy not yet measured
The Introduction mentions PLA’s compostability, while §3.4 examines crystallinity during molding and §3.6 examines thermal resistance. None of these passages addresses whether the degree of crystallinity affects PLA degradation; searches for degradation, biodegradation, and hydrolysis found no passage establishing that relationship. Page numbers were not available in our copy. (LLM, conf=0.74)
- Not checked yetcites [53] Liu, 2011, Research Progress in Toughening Modification of Poly (lactic acid), J. Polym. Sci. Part B-Polym. Phys. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
None of the sources cited for this claim have been checked yet.
In the paper
“Su et al. found that, when polylactic acid was used as the membrane material, the embedding rate of hemoglobin was very low, only 7.9%.”
§ Synthesis and Biological Application of Polylactic Acid > 3. Application > 3.1. Tissue Engineering
What the sources say
- Not checked yetcites [87] Waring, 2015, An analysis of the attrition of drug candidates from four major pharmaceutical companies, Nat. Rev. Drug Discov. source
- Not checked yetcites [88] Langer, 1993, Tissue engineering, Science source
- Could not verifycites [89] Zhang, 2009, Inhibition of Peptide Acylation in PLGA Microspheres with Water-soluble Divalent Cationic Salts, Pharm. Res. sourceExperimental — accuracy not yet measured
Our copy of Zhang et al. (2009) is entirely about octreotide acetate encapsulated in PLGA/PLA microspheres and the inhibition of peptide acylation by water-soluble divalent cationic salts (CaCl2, MnCl2); no passage mentions hemoglobin, a 'Su et al.' work, polylactic acid used as a membrane material, or a 7.9% embedding/encapsulation figure (searched: hemoglobin, Su et al. / 7.9%, encapsulation efficiency and protein loading, poly(lactic acid) membrane). The MATERIAL AND METHODS section ('Drug loading and encapsulation efficiency') reports only octreotide extraction/HPLC assay of microspheres, and the reference list contains no Su entry, so nothing in our copy either supports or contradicts the attributed finding. The decisive part is simply absent from this paper, so the claim cannot be judged against it. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Good biocompatibility also ensures that there is no inflammatory reaction in the surrounding tissue due to rejection after it enters the human body [75,76,77].”
§ Synthesis and Biological Application of Polylactic Acid > 3. Application
What the sources say
- Partly supportedcites [75] Mitragotri, 2014, Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies, Nat. Rev. Drug Discov. sourceExperimental — accuracy not yet measured
The Microparticles section describes PLGA as biocompatible and says it degrades into toxicologically acceptable products. It does not make that claim specifically for PLA or say that biocompatibility ensures no inflammatory reaction or tissue rejection after implantation. (LLM, conf=0.85)
- Partly supportedcites [76] Nottelet, 2015, Aliphatic polyesters for medical imaging and theranostic applications, Eur. J. Pharm. Biopharm. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) describes aliphatic polyesters as having demonstrated biocompatibility, which supports the general point about PLA. It does not say that PLA entering the human body causes no rejection-related inflammatory reaction in surrounding tissue; that absolute assurance is unsupported. (LLM, conf=0.87)
- Not checked yetcites [77] Tan, 2005, Diversity-oriented synthesis: Exploring the intersections between chemistry and biology, Nat. Chem. Biol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“When using a polylactic acid–polyethylene glycol copolymer, the embedding rate reached 90%.”
§ Synthesis and Biological Application of Polylactic Acid > 3. Application > 3.1. Tissue Engineering
What the sources say
- Not checked yetcites [87] Waring, 2015, An analysis of the attrition of drug candidates from four major pharmaceutical companies, Nat. Rev. Drug Discov. source
- Not checked yetcites [88] Langer, 1993, Tissue engineering, Science source
- Could not verifycites [89] Zhang, 2009, Inhibition of Peptide Acylation in PLGA Microspheres with Water-soluble Divalent Cationic Salts, Pharm. Res. sourceExperimental — accuracy not yet measured
The Introduction mentions PLA–PEG formulations only in a discussion of peptide acylation, not a 90% embedding rate. The Materials and Methods section on drug loading and encapsulation efficiency describes measurements of octreotide, not hemoglobin. Searches for hemoglobin and 90% found no passage supporting the claimed result. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Some plasticizers, such as low-molecular-weight citric acid, succinic acid, tartaric acid, and oxalate, are blended with PLA to change its mechanical and thermodynamic properties.”
§ Synthesis and Biological Application of Polylactic Acid > 2. PLA Synthesis and Properties > 2.4. Improvement of PLA Properties
What the sources say
- Not checked yetcites [66] Paul, 2003, New nanocomposite materials based on plasticized poly (l-lactide) and organo-modified montmorillonites: Thermal and morphological study, Polymer source
- Partly supportedcites [67] Paul, 2005, (Plasticized) polylactide/(organo-)clay nanocomposites by in situ intercalative polymerization, Macromol. Chem. Phys. sourceExperimental — accuracy not yet measured
Our copy of Paul et al. (2005) does support the general idea that blending a plasticizer into PLA alters its properties: the 'In situ Polymerization in Presence of PEG' and 'Masterbatch Process' sections state that PLA's brittleness means it 'needs to be plasticized in order to fulfill mechanical requirements', and that 20 wt.-% PEG 1000 lowers the PLA matrix T_g to 26 °C (from 61 °C for nonplasticized chains, 'Clay' section) while raising melting enthalpy to 42.9 J/g; the PEG triblock section reports T_g falling to 41 °C and 12 °C at 8.5 and 16.2 wt.-% PEG. However, none of the specific plasticizers the claim names — citric acid, succinic acid, tartaric acid, oxalate — appear anywhere in our copy (searched: citric, succinic, tartaric, oxalate, low-molecular-weight plasticizer); the only plasticizers treated are PEG 1000 and residual L,L-lactide monomer ('lactide is known to be a good plasticizer for P(L,L-LA)'). Mechanical properties are also invoked only as motivation, not measured. The enumerated acid plasticizers are therefore not supported by this source. (LLM, conf=0.68)
- Not checked yetcites [68] Pluta, 2006, Plasticized polylactide/clay nanocomposites. I. The role of filler content and its surface organo-modification on the physico-chemical properties, J. Polym. Sci. Part B-Polym. Phys. source
- Not checked yetcites [69] Tanoue, 2006, Preparation of poly (lactic acid)/poly(ethylene glycol)/organoclay nanocomposites by melt compounding, Polym. Compos. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
31 more claims
Create a free account to see all 78 claims and to verify the 116 references still open.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 22
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, in medicine, PLA can be applied in the areas of bioresorbent implants, surgical sutures, clamps, clips, surgical masks, or dressings [14,87,88,89,90,91].”
From Green Copolymers Based on Poly(Lactic Acid)—Short Review (2021) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This drug delivery system avoids inconsistent local concentration on account of drug release. Thus, the therapeutic effect is enhanced [90].”
From Green Copolymers Based on Poly(Lactic Acid)—Short Review (2021) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“The microspheres obtained had a porous structure inside, which advanced drug release.”
From Green Copolymers Based on Poly(Lactic Acid)—Short Review (2021) · cites this paper as [90]
The cited source says what the claim attributes to it.
In the citing paper
“In vitro release was 49% in one month, making drug action time in the body longer.”
From Green Copolymers Based on Poly(Lactic Acid)—Short Review (2021) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Synthesis and Biological Application of Polylactic Acid > 2. PLA Synthesis and Properties > 2.2. PLA Polymer
“Since LA is a chiral molecule with d-type and l-type isomers, three forms of polylactic acid are formed: poly-l-lactic acid (PLLA), poly-d-lactic acid (PDLA), and poly-d,l-lactic acid (PDLLA).”
§ Synthesis and Biological Application of Polylactic Acid > 2. PLA Synthesis and Properties > 2.2. PLA Polymer
“If l-lactic acid and d,l-lactic acid monomers are used to synthesize PLLA, the above problems are avoided [35,36].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Synthesis and Biological Application of Polylactic Acid > Abstract
“Lactic acid, as a synthetic raw material of polylactic acid, can only be obtained by sugar fermentation.”
§ Synthesis and Biological Application of Polylactic Acid > 2. PLA Synthesis and Properties > 2.1. Lactic Acid
“Chemical synthesis methods have also been applied for the industrial production of lactic acid.”
Citations
Cites
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
Pandey, K. B., & Rizvi, S. I. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9498 · Cited by 3,942
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
An Overview of Polylactides as Packaging Materials
Auras, R., Harte, B., & Selke, S. (2004) · Macromolecular Bioscience · doi:10.1002/mabi.200400043 · Cited by 3,454 · cited 2×
“Synthesis of polylactic acid (PLA) from L‐ and D‐lactic acids [28].”
BackgroundDietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Research works printed but not linked: 1
- Bud, 1993, A history of lactic-acid making–A chapter in the history of biotechnology-benninga,h, Ann. Sci., 50, 597
Cited by
Balla, E., Daniilidis, V., Karlioti, G., Kalamas, T., Stefanidou, M., Bikiaris, N. D., Vlachopoulos, A., Koumentakou, I., & Bikiaris, D. N. (2021) · Polymers · doi:10.3390/polym13111822 · Cited by 655
“So, this method is employed only if the polymer of low molecular weight is required [34].”
BackgroundMethodInfluentialDas, A., Ringu, T., Ghosh, S., & Pramanik, N. (2023) · Polymer Bulletin · doi:10.1007/s00289-022-04443-4 · Cited by 380
Organic acids production from lactic acid bacteria: A preservation approach
Punia Bangar, S., Suri, S., Trif, M., & Ozogul, F. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101615 · Cited by 336
3D printing of polylactic acid: recent advances and opportunities
Joseph, T. M., Kallingal, A., Suresh, A. M., Mahapatra, D. K., Hasanin, M. S., Haponiuk, J., & Thomas, S. (2023) · The International Journal of Advanced Manufacturing Technology · doi:10.1007/s00170-022-10795-y · Cited by 313
Strategies for Bone Regeneration: From Graft to Tissue Engineering
Battafarano, G., Rossi, M., De Martino, V., Marampon, F., Borro, L., Secinaro, A., & Del Fattore, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031128 · Cited by 295
“Non-toxic and FDA approved synthetic polymers include: PLA (polylactic acid) and PGA (polyglycolic acid), showing the best mechanical properties, being non-inflammatory, biocompatible and biodegradable and supporting cell adhesion [72,73]; biodegradable PLGA (polylactic co-glycolic acid), providing support for cell ad…”
Background
Metadata
- Authors
- Li, G., Zhao, M., Xu, F., Yang, B., Li, X., Meng, X., Teng, L., Sun, F., & Li, Y.
- Affiliations
- Jilin University (CN)
- Corresponding author
- Sun, Fengying
- Li, Youxin
- ORCID
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-10-29
- Volume
- 25
- Issue
- 21
- Pages
- 5023
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7662581
- OpenAlex
- W3096086014
- Cited by
- 492
- References
- 140
- Citations by year
- 2026: 55 · 2025: 115 · 2024: 112 · 2023: 105 · 2022: 71 · 2021: 34
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- People's Government of Jilin Province (20180101269JC)
- Topics
- Physical Sciences › Materials Science › Biomaterials › biodegradable polymer synthesis and properties
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Health Sciences › Medicine › Surgery › Surgical Sutures and Adhesives
- Keywords
- polylactic acid, lactic acid, biodegradable polymers, biocompatibility, polymer synthesis, polymer modification, drug delivery, implants, tissue engineering, biodegradation, sugar fermentation
- MeSH terms
- Biocompatible Materials, Humans, Polyesters, Drug Delivery Systems, Prostheses and Implants, Tissue Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synthesis and Biological Application of Polylactic Acid. https://app.cochat.ai/papers/10.3390/molecules25215023
- The paper
- Li, G., Zhao, M., Xu, F., Yang, B., Li, X., Meng, X., Teng, L., Sun, F., & Li, Y. (2020). Synthesis and Biological Application of Polylactic Acid. Molecules. https://doi.org/10.3390/molecules25215023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.